Read More
FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia"
Post a Comment